Ensol Biosciences (XKRX:140610) FCF Yield % : -12.85 (As of Jun. 23, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ensol Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ensol Biosciences's Trailing 12-Month Free Cash Flow is ₩-8,206.0 Mil, and Market Cap is ₩63,884.1 Mil. Therefore, Ensol Biosciences's FCF Yield % for today is -12.85%.

The historical rank and industry rank for Ensol Biosciences's FCF Yield % or its related term are showing as below:

XKRX:140610' s FCF Yield % Range Over the Past 10 Years
Min: -23.73 Med: -5.18 Max: -2.63
Current: -12.85

During the past 10 years, the highest FCF Yield % of Ensol Biosciences was -2.63%. The lowest was -23.73%. And the median was -5.18%.

XKRX:140610's FCF Yield % is ranked better than
53.1% of 1550 companies
in the Biotechnology industry
Industry Median: -14.395 vs XKRX:140610: -12.85

Ensol Biosciences's FCF Margin % for the quarter that ended in Dec. 2023 was -4,648.12%.

Ensol Biosciences FCF Yield % Historical Data

The historical data trend for Ensol Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensol Biosciences FCF Yield % Chart

Ensol Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-6.56

-4.20

-5.19

-9.12

-12.18

Ensol Biosciences Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
FCF Yield %	Get a 7-Day Free Trial					-6.56	-4.20	-5.19	-9.12	-12.18

Competitive Comparison of Ensol Biosciences's FCF Yield %

For the Biotechnology subindustry, Ensol Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ensol Biosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ensol Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ensol Biosciences's FCF Yield % falls into.

Ensol Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ensol Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-8206.032	/	67348.916
	=	-12.18%

Ensol Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-8206.032	*	1	/	67348.916
	=	-12.18%

Ensol Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Ensol Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ensol Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ensol Biosciences (XKRX:140610) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ensol Biosciences Inc (XKRX:140610) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

51, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34036

Website

http://www.ensolbio.co.kr

Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.

Ensol Biosciences (XKRX:140610) Headlines

No Headlines